STRYKER CORP
Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.
CAPITALIZATION 12/31/25
| ($ millions) | Amount | % |
|---|---|---|
| Total debt | 15,859 | 41.4 |
| Stockholders' equity | 22,420 | 58.6 |
| Total capitalization | 38,279 | 100.0 |
383,573,046 shares outstanding at 30 June 2026 (cover page of the 10-Q filed 31 July 2026).
LONG-TERM DEBT 12/31/25
| ($ millions) | Amount |
|---|---|
| Long-term debt, incl. current maturities | 15,859 |
| Long-term debt, noncurrent | 14,859 |
| Current maturities | 1,000 |
| Short-term borrowings / commercial paper | 0 |
CAPITAL STOCK 12/31/25
| Common shares authorized | 1,000,000,000 |
| Par or stated value per share ($) | 0.1 |
| Outstanding at 6/30/26 | 383,573,046 |
DIVIDENDS DECLARED/PAID
| Fiscal year | Per share $ | Payout % |
|---|---|---|
| 2025 | – | – |
| 2024 | – | – |
| 2023 | – | – |
| 2022 | – | – |
| 2021 | – | – |
HISTORY AND BUSINESS
HISTORY: Incorporated in Michigan.
BUSINESS: Classified by the SEC under Standard Industrial Classification 3841, Surgical & Medical Instruments & Apparatus. Large accelerated filer. Principal executive office: 1941 Stryker Way, Portage, MI 49002. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.
CONSOLIDATED INCOME ACCOUNT, YEARS ENDED
| ($ millions) | 12/31/25 | 12/31/24 | 12/31/23 |
|---|---|---|---|
| Revenues | 25,116 | 22,595 | 20,498 |
| Cost of revenues | 9,051 | 8,155 | 7,440 |
| Gross profit | 16,065 | 14,440 | 13,058 |
| Research and development | 1,623 | 1,466 | 1,388 |
| Selling, general and administrative | 8,651 | 7,685 | 7,111 |
| Depreciation and amortization | 1,570 | 1,426 | 1,341 |
| Operating income | 4,889 | 3,689 | 3,888 |
| Interest expense | 607 | 409 | 363 |
| Income before income taxes | 4,514 | 3,492 | 3,673 |
| Income taxes | 1,268 | 499 | 508 |
| Net income | 3,246 | 2,993 | 3,165 |
| Earned per share, diluted ($) | 8.40 | 7.76 | 8.25 |
| Dividends per share ($) | – | – | – |
CONSOLIDATED BALANCE SHEET
| ($ millions) | 12/31/25 | 12/31/24 |
|---|---|---|
| Cash and equivalents | 4,011 | 3,652 |
| Receivables, net | 4,039 | 3,987 |
| Inventories | 5,310 | 4,774 |
| Total current assets | 14,755 | 14,847 |
| Property, plant and equipment, net | 3,876 | 3,448 |
| Goodwill | 19,291 | 15,855 |
| Total assets | 47,844 | 42,971 |
| Total current liabilities | 7,794 | 7,616 |
| Long-term debt | 14,859 | 12,188 |
| Total liabilities | 25,424 | 22,337 |
| Total liabilities and equity | 47,844 | 42,971 |
TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)
| Fiscal year ended | Revenues | Oper. income | Net income | Net margin % | EPS diluted $ | Div. per share $ | Oper. cash flow | Capital expend. | Free cash flow | Total assets | Total liabilities | Total debt | Stockholders' equity | ROE % | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/31/25 | 25,116 | 4,889 | 3,246 | 12.9 | 8.40 | – | 5,044 | 761 | 4,283 | 47,844 | 25,424 | 15,859 | 22,420 | 14.5 | 0.71 |
| 12/31/24 | 22,595 | 3,689 | 2,993 | 13.2 | 7.76 | – | 4,242 | 755 | 3,487 | 42,971 | 22,337 | 13,597 | 20,634 | 14.5 | 0.66 |
| 12/31/23 | 20,498 | 3,888 | 3,165 | 15.4 | 8.25 | – | 3,711 | 575 | 3,136 | 39,912 | 21,319 | 12,995 | 18,593 | 17.0 | 0.70 |
| 12/31/22 | 18,449 | 2,841 | 2,358 | 12.8 | 6.17 | – | 2,624 | 588 | 2,036 | 36,884 | 20,268 | 13,048 | 16,616 | 14.2 | 0.79 |
| 12/31/21 | 17,108 | 2,584 | 1,994 | 11.7 | 5.21 | – | 3,263 | 525 | 2,738 | 34,631 | 19,754 | 12,479 | 14,877 | 13.4 | 0.84 |
| 12/31/20 | 14,351 | 2,223 | 1,599 | 11.1 | 4.20 | – | 3,277 | 487 | 2,790 | 34,330 | 21,246 | 13,991 | 13,084 | 12.2 | 1.07 |
| 12/31/19 | 14,884 | 2,713 | 2,083 | 14.0 | 5.48 | – | 2,191 | 649 | 1,542 | 30,167 | 17,360 | 11,090 | 12,807 | 16.3 | 0.87 |
| 12/31/18 | 13,601 | 2,537 | 3,553 | 26.1 | 9.34 | – | 2,610 | 572 | 2,038 | 27,229 | 15,499 | 9,859 | 11,730 | 30.3 | 0.84 |
| 12/31/17 | 12,444 | 2,297 | 1,020 | 8.2 | 2.68 | – | 1,559 | 598 | 961 | 22,197 | 12,217 | 7,222 | 9,966 | 10.2 | 0.72 |
| 12/31/16 | 11,325 | 2,175 | 1,647 | 14.5 | 4.35 | 1.56 | 1,915 | 490 | 1,425 | 20,435 | 10,885 | 7,114 | 9,550 | 17.2 | 0.74 |
Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.
REGISTRANT:
STRYKER CORP
CIK 310764 · EIN 38-1239739
PRINCIPAL OFFICE:
1941 Stryker Way, Portage, MI 49002
Tel.: 2693852600
INCORPORATED:
Michigan
INDUSTRY (SEC SIC CODE):
3841 · Surgical & Medical Instruments & Apparatus
FILER STATUS:
Large accelerated filer
LATEST ANNUAL REPORT:
10-K for period ended 12/31/25, filed 11 February 2026
Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/11/26) · 10-K FY2024 (filed 2/12/25) · 10-K FY2023 (filed 2/14/24) · 10-K FY2022 (filed 2/10/23) · 10-K FY2021 (filed 2/11/22) · 10-K FY2020 (filed 2/11/21) · 10-K FY2019 (filed 2/6/20) · 10-K FY2018 (filed 2/7/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.
Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.